Back to Ingredient Dictionary

TRANEXAMOYL DIPEPTIDE-23

Description

Tranexamoyl Dipeptide-23 is an innovative peptide-based ingredient gaining attention in advanced skincare formulations. This synthetic compound combines tranexamic acid with a dipeptide sequence, specifically designed to target hyperpigmentation and uneven skin tone.

The ingredient works by inhibiting melanin synthesis through multiple pathways. It interferes with the interaction between keratinocytes and melanocytes, reducing the transfer of melanin to the skin's surface. Additionally, Tranexamoyl Dipeptide-23 helps to suppress inflammatory mediators that can trigger excess pigment production.

Clinical studies have shown that Tranexamoyl Dipeptide-23 can effectively reduce the appearance of dark spots and melasma, with visible results typically observed within 4-8 weeks of consistent use. Its efficacy is comparable to hydroquinone, but with a better safety profile, making it suitable for long-term use.

This ingredient is particularly beneficial in formulations targeting post-inflammatory hyperpigmentation, sun damage, and age spots. It is compatible with most skincare ingredients and can be incorporated into various product types, including serums, creams, and targeted treatments. Optimal concentration ranges from 1-5%, depending on the specific formulation and desired effects.